Monitor for any subsequent 8-K or prospectus supplement announcing warrant exercise and share issuance. The effectiveness removes the last regulatory barrier to immediate dilution — any insider selling or large block trades post-effectiveness would signal near-term price pressure.
Price Chart
Executive Summary
GeoVax Labs' S-1 registration statement (File No. 333-298989) became effective on September 23, 2026, allowing the resale of up to 7.64 million common shares by institutional investors upon warrant exercise. The company receives no proceeds from the resale but may receive up to ~$8.6 million if warrants are cash-exercised. With only ~$1.3 million cash and a going concern opinion, this effectiveness creates immediate dilution overhang for a clinical-stage biotech with no product revenue.
Key Facts
- S-1 registration effective 2026-09-23 for resale of up to 7.64 million shares by institutional investors
- Shares issuable upon exercise of warrants from May 2026 capital raises (warrant inducement and PIPE)
- Company receives no proceeds from resale; may receive up to ~$8.6 million if warrants cash-exercised
- GeoVax had only ~$1.3 million cash as of March 31, 2026, with a going concern opinion
- Clinical-stage biotech with no product revenue
Financial Impact
Potential dilution of up to 7.64 million shares (significant relative to current float); potential cash inflow of ~$8.6 million if warrants exercised
Risk Factors
- Immediate dilution overhang from potential resale of 7.64 million shares
- Cash runway remains critically low (~$1.3M) with no product revenue
- Going concern risk persists if warrants are not exercised for cash
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003048 |
| Document: 9999999995-26-003048-index.html | 9999999995-26-003048 |
| Document: 9999999995-26-003048.txt | 9999999995-26-003048 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $0.2032 | awaiting T+60 | — | $0.2059 (−1.33%) |
Sep 24, 2026 4w ago | EFFECT | $0.3603 | awaiting T+60 | — | $0.2059 (+42.85%) |
Jun 4, 2026 20w ago | EFFECT | $1.79 $0.7210 | ▲ +59.72% | ▲ +61.60% | $0.2059 (+88.50%) |
May 26, 2026 22w ago | S-1 | $3.49 $0.5947 | ▼ −82.96% | ▼ −85.68% | $0.2059 (−94.10%) |
May 19, 2026 22w ago | 8-K | $2.23 $0.7180 | ▲ +67.80% | ▲ +72.81% | $0.2059 (+90.77%) |
May 14, 2026 23w ago | 8-K | $1.23 $0.7700 | ▲ +37.40% | ▲ +41.91% | $0.2059 (+83.26%) |
May 7, 2026 24w ago | 8-K | $1.67 $0.7620 | ▲ +54.37% | ▲ +59.21% | $0.2059 (+87.67%) |
Apr 22, 2026 26w ago | EFFECT | $1.17 $0.9742 | ▼ −16.73% | ▼ −21.51% | $0.2059 (−82.40%) |
Apr 20, 2026 27w ago | EFFECT | $1.17 $1.01 | ▲ +13.68% | ▲ +20.45% | $0.2059 (+82.40%) |
Apr 15, 2026 27w ago | 8-K | $1.23 $1.11 | ▲ +9.76% | ▲ +16.80% | $0.2059 (+83.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers